Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.

Subrata GhoshBrian G FeaganElyssa OttChristopher GasinkBridget GodwinColleen MaranoYe MiaoTony MaEdward V LoftusWilliam J SandbornSilvio DaneseMaria T AbreuBruce E Sands

Published in: Journal of Crohn's & colitis (2024)

NCT00265122, NCT00771667, NCT01369329, NCT01369342, NCT01369355, NCT02407236.

Keyphrases

ulcerative colitis
randomized controlled trial
clinical trial
data analysis
phase iii